Annual Current Ratio
2.36
+2.22+1585.71%
01 December 2023
Summary:
Altamira Therapeutics annual current ratio is currently 2.36, with the most recent change of +2.22 (+1585.71%) on 01 December 2023. During the last 3 years, it has fallen by -1.47 (-38.38%). CYTO annual current ratio is now -81.86% below its all-time high of 13.01, reached on 31 December 2014.CYTO Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
0.43
-1.93-81.78%
01 June 2024
Summary:
Altamira Therapeutics quarterly current ratio is currently 0.43, with the most recent change of -1.93 (-81.78%) on 01 June 2024. Over the past year, it has increased by +0.11 (+34.38%). CYTO quarterly current ratio is now -96.69% below its all-time high of 13.01, reached on 31 December 2014.CYTO Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTO Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1585.7% | +34.4% |
| 3 y3 years | -38.4% | -85.6% |
| 5 y5 years | +77.4% | -87.8% |
CYTO Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -38.4% | +1585.7% | -85.6% | +207.1% |
| 5 y | 5 years | -38.4% | +1585.7% | -88.8% | +207.1% |
| alltime | all time | -81.9% | +1585.7% | -96.7% | +207.1% |
Altamira Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | 0.43(-81.8%) |
| Dec 2023 | 2.36(+1585.7%) | 2.36(+637.5%) |
| June 2023 | - | 0.32(+128.6%) |
| Dec 2022 | 0.14(-83.3%) | 0.14(-30.0%) |
| June 2022 | - | 0.20(-76.2%) |
| Dec 2021 | 0.84(-78.1%) | 0.84(-71.8%) |
| June 2021 | - | 2.98(-22.2%) |
| Dec 2020 | 3.83(+268.3%) | 3.83(+2293.8%) |
| June 2020 | - | 0.16(-84.6%) |
| Dec 2019 | 1.04(-21.8%) | 1.04(-70.6%) |
| June 2019 | - | 3.54(+166.2%) |
| Dec 2018 | 1.33(-12.5%) | 1.33(+46.2%) |
| Sept 2018 | - | 0.91(+62.5%) |
| June 2018 | - | 0.56(-60.0%) |
| Mar 2018 | - | 1.40(-7.9%) |
| Dec 2017 | 1.52 | 1.52(-18.3%) |
| Sept 2017 | - | 1.86(-27.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2017 | - | 2.56(-23.4%) |
| Mar 2017 | - | 3.34(-11.2%) |
| Dec 2016 | 3.76(-54.6%) | 3.76(-20.7%) |
| Sept 2016 | - | 4.74(-13.7%) |
| June 2016 | - | 5.49(-24.4%) |
| Mar 2016 | - | 7.26(-12.3%) |
| Dec 2015 | 8.28(-36.4%) | 8.28(-12.2%) |
| Sept 2015 | - | 9.43(-5.9%) |
| June 2015 | - | 10.02(-0.5%) |
| Mar 2015 | - | 10.07(-22.6%) |
| Dec 2014 | 13.01(+779.1%) | 13.01(+18.9%) |
| Sept 2014 | - | 10.94(+115.8%) |
| June 2014 | - | 5.07(-12.1%) |
| Mar 2014 | - | 5.77(+289.9%) |
| Dec 2013 | 1.48(+236.4%) | 1.48 |
| Dec 2012 | 0.44(-68.8%) | - |
| Dec 2011 | 1.41 | - |
FAQ
- What is Altamira Therapeutics annual current ratio?
- What is the all time high annual current ratio for Altamira Therapeutics?
- What is Altamira Therapeutics annual current ratio year-on-year change?
- What is Altamira Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Altamira Therapeutics?
- What is Altamira Therapeutics quarterly current ratio year-on-year change?
What is Altamira Therapeutics annual current ratio?
The current annual current ratio of CYTO is 2.36
What is the all time high annual current ratio for Altamira Therapeutics?
Altamira Therapeutics all-time high annual current ratio is 13.01
What is Altamira Therapeutics annual current ratio year-on-year change?
Over the past year, CYTO annual current ratio has changed by +2.22 (+1585.71%)
What is Altamira Therapeutics quarterly current ratio?
The current quarterly current ratio of CYTO is 0.43
What is the all time high quarterly current ratio for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly current ratio is 13.01
What is Altamira Therapeutics quarterly current ratio year-on-year change?
Over the past year, CYTO quarterly current ratio has changed by +0.11 (+34.38%)